Similarly, MAFK was also reported to promote the progression of triple-negative breast cancer, in which MAFK notably induced epithelial-mesenchymal transition (EMT) and tumor invasion by regulating the targeted gene GPNMB40. This evidence concerns the gene MAFK and triple-negative breast carcinoma.